Study Evaluating the Parent-child Relationship During the Hospitalisation of a Parent in Long-term Protective Isolation
VIK-e2
VIK-e2 - Observational, Multicenter Prospective Study Evaluating Parent-child Relationship with the Setting Up of a Mobile Telepresence Robot for Patients with Children Aged 15 Years or Less and Hospitalised in Long-term Protective Isolation
1 other identifier
observational
31
1 country
3
Brief Summary
The intensive treatments of certain cancers and haemopathies require the implementation of a protective isolation from external micro-organisms for a period of several weeks. This isolation implies a limitation of visitors and sometimes prohibits access to young children. This raises questions concerning the maintenance of family links, and in particular the parent-child relationship as well as the psychological and emotional isolation of hospitalised patients and the resulting psychological effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2021
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 24, 2021
CompletedFirst Submitted
Initial submission to the registry
April 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2023
CompletedFebruary 28, 2025
February 1, 2025
2.3 years
April 8, 2021
February 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation
Observation of communications between the hospitalised patient and his/her chid(children) by a specialist in human and social sciences
Through study completion, an average of 3 months
Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation
Interview with the hospitalised patient (parent) by a specialist in human and social sciences
Through study completion, an average of 3 months
Secondary Outcomes (5)
Evaluation of the experience linked to the robot availability on the concerned persons (patient, children, person on charge of children)
Through study completion, an average of 3 months
Evaluation of patient's satisfaction
Through study completion, an average of 3 months
Evaluation of the impact of robot use on patient's coping strategies (adaptation and adjustment to illness and hospitalisation)
Through study completion, an average of 3 months
Evaluation of patient's experience of hospitalisation
Through study completion, an average of 3 months
Evaluation of the impact of the robot's presence at home on the children and the person in charge of the children during patient's hospitalisation
Through study completion, an average of 3 months
Interventions
Telepresence robot installed at child's home during parent's hospitalisation in long term protective isolation for maintaining parent-child ink (only children aged 15 years or less are concerned)
Eligibility Criteria
Observational prospective study, multicenter of parent-child relationship assessment following the setting up of a mobile telepresence robot for patients with children aged 15 years or less and hospitalised in long-term protective isolation. This study is based on semi-directed interviews and observations made during patient's hospitalisation and when patient returns at home.
You may qualify if:
- Age≥ 18
- Patient with at least one child aged 15 or under
- Pathology requiring a prolonged hospitalization in protective isolation
- Consent dated and signed
You may not qualify if:
- Impaired cognitive functions
- Performance Status -Eastern Cooperative Oncology Group (PS-ECOG) = 4
- Difficulties in speaking and understanding French
- Patient under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Centre Leon Berard
Lyon, 69008, France
Centre Hospitalier Lyon Sud
Lyon, France
Institut Paoli Calmettes
Marseille, 13000, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
GUILLERMIN Yann, MD
Centre Leon Berard
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2021
First Posted
April 23, 2021
Study Start
February 24, 2021
Primary Completion
June 3, 2023
Study Completion
June 3, 2023
Last Updated
February 28, 2025
Record last verified: 2025-02